Studies on the relationship between vitamin D3 status and urinary excretion of calcium in healthy subjects: Effects of increased levels of 25-hydroxyvitamin D₃

References

• Berlin T, Björkhem I, Collste L, Holmberg I, Wijkstrom H. Relation between hypercalciuria and vitamin D3-status in patients with urolithiasis. Scand J Urol Nephrol 1982; 16: 269–73
   PubMed Web of Science ®Google Scholar
• Berlin T, Holmberg I, Björkhem L. High circulating levels of 25-hydroxyvitamin D3 in renal stone formers with hyperansorptive hypercalciuria. Scand J Clin Lab Invest 1986; 46: 367–74
   PubMed Web of Science ®Google Scholar
• Elomaa I, Karonen S L, Kairento A L, Pelkonen R. Seasonal variation of urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level in relation to renal stone formation. Scand J Urol Nephrol 1982; 16: 155–161
   PubMed Web of Science ®Google Scholar
• Jongen M JM. The role of vitamin D in the pathogenesis of urinary calcium-stone disease. PhD Thesis, Vrije University, Amsterdam 1983
   Google Scholar
• Netelenbos J C, Jongen M JM, van der Vijgh W JF, Lips P, van Ginkel F C. Vitamin D status in urinary calcium stone formation. Arch Intern Med 1985; 145: 681–4
   Google Scholar
• Kaplan R A, Haussler M R, Deftos L J, Bone H, Pak C YC. The role of 1,25 dihydroxyvitamin D, in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 1977; 59: 756–60
   PubMed Web of Science ®Google Scholar
• Shen F H, Baylink D J, Nielsen R L, Sherrard D J, Ivey J L, Haussler M R. Increased serum 1,25-dihydroxyvitamin D3 in idiopathic hypercalciuria. J Lab Clin Med 1977; 90: 955–62
   PubMed Web of Science ®Google Scholar
• Van Den Berg C J, Kumar R, Wilson D M, Heath H, Smith L H. Ortophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D3 concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980; 51: 998–1001
   PubMed Web of Science ®Google Scholar
• Coe F L, Favus M J, Crockett T, et al. Effects of low-calcium diet on urinary excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982; 72: 25–32
   PubMed Web of Science ®Google Scholar
• Broadus A E, Insogna K L, Lang R, et al. A consideration of the hormonal basis and phosphate leak hypothesis of absorptive hypercalciuria. J Clin Endocrinol Metab 1984; 58: 161–9
   PubMed Web of Science ®Google Scholar
• Broadus A E, Insogna K L, Lang R, Ellison A F, Dreyer B E. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 1984; 311: 73–80
   PubMed Web of Science ®Google Scholar
• De Luca H F. Vitamin D, metabolism and function. Monographs on Endocrinology. Springer Verlag, New York 1979
   Google Scholar
• Caldas A E, Gray R W, Lemann J. The simultaneous measurement of vitamin D metabolites in plasma: studies in healthy adults and in patients with calcium nephrolithiasis. J Lab Clin Med 1978; 91: 840–9
   PubMed Web of Science ®Google Scholar
• Schmidt-Gayk H, Tschöpe W, Schellenberg B, Schlierf G, Walch S. Vitamin D-Stoffwechsel bei Urolithiasis: Neuere Befunde und Untersuchungs-metoden. Therapiewoche 1979; 29: 2137–41
   Google Scholar
• Holmberg I, Larsson A. Seasonal variation of vitamin D3 and 25-hydroxyvitamin D, in human serum. Clin Chim Acta 1980; 100: 173–4
   Google Scholar
• Pak C YC, Kaplan R, Bone H, Townsend J, Waters O. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 1975; 292: 497–500
   PubMed Web of Science ®Google Scholar
• Björkhem I, Holmberg I. Mass fragmentography of 25 hydroxyvitamin D3. Life Sci II 1978; 167–74, Quantitative mass spectrometry
   Google Scholar
• Björkhem I, Holmberg I. Mass fragmentographic assay of 25 hydroxyvitamin D3. Methods in Enzymology 1980; 67: 385–93
   PubMedGoogle Scholar
• Reinhard T A, Horst R L, Orf J W, Hollis B W. A microassay for 1,25-dihydroxyvitamin D3 not requiring HPLC. Application to clinical studies. J Clin Endocrinol Metab 1984; 59: 91–8
   Google Scholar
• Stanbury S W, Mawer E B. Physiological aspects of vitamin D metabolism. Vitamin D, D EM Lawson. Academic Press, London 1978; 303–41
   Google Scholar
• Peacock M, Selby P L, Francis R M, Brown W B, Hordon L. Vitamin D deficiency, insufficiency, sufficiency and intoxication. What do they mean?. Vitamin D, chemical, biochemical and clinical update, A W Norman, K Schaefer, H G Grigoleit, D Herrath. Walter de Gruyter, Berlin 1985; 569–70
   Google Scholar
• Parry E S, Lister I S. Sunlight and hypercalciuria. Lancet 1975; 1: 1063–5
   PubMed Web of Science ®Google Scholar
• Wilhelm F, Norman A W. 24R, 25-hydroxy-vitamin D, regulates, 1,25-dihydroxyvitamin D, binding to its chick intestinal receptor. Biochem Biophys Res Commun 1985; 126: 496–501
   PubMed Web of Science ®Google Scholar
• Holmberg I, Berlin T, Ewerth S, Björkhem I. 25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3. Scand J Clin Lab Invest 1986; 46: 785–90
   Web of Science ®Google Scholar
• Bell N H, Shaw S, Turner R T. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest 1984; 74: 1540–4
   PubMed Web of Science ®Google Scholar